Cochlear reinstates dividend as outlook brightens

MELBOURNE: Cochlear boss Dig Howitt expects the rollout of COVID-19 vaccines to take ... read more

Plasma collection problems cloud CSL’s bumper results

SYDNEY: CSL recorded its fastest earnings growth in memory, with net profit leaping ... read more

Luye taps JPMorgan to find Healthe buyer

SYDNEY: Australia’s third largest private hospital group is back on the auction block.

Five ... read more

CSL share price jumps after long awaited AZ approval

SYDNEY: The nation’s Therapeutic Goods Administration has at last granted approval for the ... read more